- $2.13bn
- $3.13bn
- $5.97bn
- 92
- 87
- 85
- 99
Annual cashflow statement for Ardent Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 245 | 265 | 129 | 300 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | -16 | -163 | 4.19 | 26.7 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -188 | -325 | -56.3 | -182 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 147 | -38.4 | 222 | 315 |
| Capital Expenditures | -139 | -151 | -137 | -188 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 2.74 | 198 | -0.575 | -33 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -136 | 46.6 | -138 | -220 |
| Financing Cash Flow Items | -199 | -254 | -95.2 | 129 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -284 | -270 | -102 | 24.6 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -273 | -262 | -18.5 | 119 |